Point72 Asset Management, L.P.
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1603466
STAMFORD, CT
Position in BMRN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$67,743,146
+$41,664,252 QoQ
Shares Held
1,199,206
+173.3% QoQ
Ownership
0.620%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Derivatives in BMRN
reported options exposure · as of Mar 31, 2026CallValue
$5,649,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in BMRN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,649,000 | 100,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $67,743,146 | 1,199,206 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $26,078,894 | 438,817 | Shares | Defined | 2026-02-17 | |
| 2025-03-31 | $27,975,567 | 395,750 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $17,512,838 | 266,436 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $19,719,000 | 300,000 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $21,087,000 | 300,000 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $13,897,598 | 197,718 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $117,535,184 | 1,345,720 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $43,900,026 | 455,300 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $74,171,283 | 716,700 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $50,472,058 | 595,400 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,254,069 | 147,871 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $28,283,055 | 366,836 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $6,545,790 | 84,900 | Call | Defined | 2022-05-16 | |
| 2021-12-31 | $72,605,676 | 821,796 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $61,197,371 | 791,789 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $30,580,760 | 366,500 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $19,368,315 | 256,500 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $33,418,659 | 381,100 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $71,796,163 | 943,693 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||